Tuesday, May 18, 2021

Sanofi-GSK COVID vax shows strong immune responses in Phase 2 trial

A COVID-19 vaccine developed by pharmaceutical giants Sanofi and Glaxo Smith Kline (GSK) has shown strong rates of neutralising antibody responses against the infectious Coronavirus disease in the Phase-II trial.

from Zee News :Zee News - Health https://ift.tt/3hyEotX
via IFTTT

No comments:

Post a Comment

Market full of ‘fake yellow’ bananas? Easy tips to spot the real ones

Chemicals are used to speed up the ripening process so fruits can be sold faster. Therefore, everyone must know how to identify naturally r...